ESTABLISHMENT OF HUMAN LENS EPITHELIAL CELL LINES
人晶状体上皮细胞系的建立
基本信息
- 批准号:6518691
- 负责人:
- 金额:$ 21.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-07-01 至 2005-05-31
- 项目状态:已结题
- 来源:
- 关键词:age difference cataract cell growth regulation cell line crystallins electroporation enzyme activity epithelium genetic promoter element genetic regulatory element human tissue isozymes lens organ culture phenotype polymerase chain reaction restriction fragment length polymorphism telomerase tissue /cell preparation transfection western blottings
项目摘要
The aim of cataract research is to prevent or delay human cataract formation. Cataract is the world's leading cause of blindness. Impaired epithelial function invariably leads to a loss of transparency. A therapy aimed at delaying or preventing human cataracts needs to be evaluated on human lens epithelial cells (HLECs). Due to the scarcity of viable human lenses, numerous investigators have tried to culture HLECs. However, normal, HLECs complete 2-4 passages in culture and undergo senescence. HLECs have properties different from those of the lower species. For example, lens epithelial lines can be established from lower species using standard techniques; this is not true of HLECs. Metabolic fluxes in various species are also different relative to the polyol pathway. Aldose reductase activity is high in the dog and rat lens, very low in the human lens and absent in the mouse. Although viral transformation of HLECs permits growth, virally transformed cells have properties that are different from their non-transformed counterparts. Experiments are needed to determine the properties of normal HLECs. Our aims are to establish a reliable supply of normal HLECs, characterize them and make them available to the eye research community. This is absolutely necessary for future studies. The aims are to: 1. Determine if a wound-healing environment permits the long-term growth of normal HLECs from young, old and cataractous lenses. 2. Determine if the introduction of telomerase into HLECs permits establishment of lines fromlens explants, permits established lines to overcome senescence, and if the presence of telomerase maintains the diploid state and allows maintenance of in vivo characteristics. Determine the ploidy, isoenzyme phenotyping, DNA fingerprint, alphaA and alphaB crystallin expression, and growth in cells generated Aim 1 or 2. 3. Determine if there are metabolic differences between cells from young, old and cataractous lenses. 4. Identify lens-specific regulatory elements in the promoters of genes that encode gamma-glutamylcysteine synthetase (GCS).
白内障研究的目的是预防或延缓人类白内障的形成。白内障是世界上致盲的主要原因。上皮功能受损总是导致透明性的丧失。一种旨在延缓或预防人类白内障的治疗方法需要在人晶状体上皮细胞(HLECs)上进行评估。由于缺乏可行的人类晶状体,许多研究者试图培养高晶状体。然而,正常的HLECs在培养中完成2-4代并经历衰老。HLECs具有不同于低等物种的特性。例如,可以使用标准技术从较低物种建立晶状体上皮细胞系;这对HLECs来说不是真的。不同物种的代谢通量也不同于多元醇途径。醛糖还原酶活性在狗和大鼠晶状体中很高,在人晶状体中很低,在小鼠中不存在。虽然病毒转化的HLECs允许生长,但病毒转化的细胞具有不同于非转化细胞的特性。需要通过实验来确定正常的HLECs的性质。我们的目标是建立正常hlec的可靠供应,对其进行表征,并将其提供给眼科研究界。这对今后的研究是绝对必要的。其目的是:1。确定伤口愈合的环境是否允许年轻、年老和白内障晶状体的正常HLECs长期生长。2. 确定端粒酶引入HLECs是否允许从外植体建立系,是否允许建立系克服衰老,以及端粒酶的存在是否维持二倍体状态并允许维持体内特征。测定其倍性、同工酶表型、DNA指纹图谱、α a和α b结晶蛋白表达和生长情况。3. 确定年轻、年老和白内障晶状体细胞之间是否存在代谢差异。4. 在编码γ -谷氨酰半胱氨酸合成酶(GCS)的基因启动子中鉴定晶状体特异性调控元件。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Identification of caveolae and their signature proteins caveolin 1 and 2 in the lens.
- DOI:10.1016/j.exer.2004.06.019
- 发表时间:2004-10
- 期刊:
- 影响因子:3.4
- 作者:W. Lo;Cheng Zhou;J. Reddan
- 通讯作者:W. Lo;Cheng Zhou;J. Reddan
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John R. Reddan其他文献
John R. Reddan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John R. Reddan', 18)}}的其他基金
ESTABLISHMENT OF HUMAN LENS EPITHELIAL CELL LINES
人晶状体上皮细胞系的建立
- 批准号:
6384899 - 财政年份:2000
- 资助金额:
$ 21.3万 - 项目类别:
ESTABLISHMENT OF HUMAN LENS EPITHELIAL CELL LINES
人晶状体上皮细胞系的建立
- 批准号:
6165727 - 财政年份:2000
- 资助金额:
$ 21.3万 - 项目类别:
相似海外基金
Development of a tele-mentoring system integrated into an ultra-portable surgical microscope to treat cataract in underserved populations
开发集成到超便携式手术显微镜中的远程指导系统,以治疗服务不足人群的白内障
- 批准号:
10602749 - 财政年份:2023
- 资助金额:
$ 21.3万 - 项目类别:
Improving Outcomes in Cataract Surgery: Intraocular Lenses (IOLs) Resistant to Cell Growth
改善白内障手术的效果:抗细胞生长的人工晶状体 (IOL)
- 批准号:
10841859 - 财政年份:2023
- 资助金额:
$ 21.3万 - 项目类别:
Role of the S100 Family of Proteins in Lens Physiology and Cataract
S100 蛋白家族在晶状体生理学和白内障中的作用
- 批准号:
10560827 - 财政年份:2023
- 资助金额:
$ 21.3万 - 项目类别:
Probing the specific interactions of AlphaA- crystallin and its aging- and cataract-associated forms with lens cell membrane mimics
探讨 AlphaA-晶状体蛋白及其与衰老和白内障相关的形式与晶状体细胞膜模拟物的特定相互作用
- 批准号:
10667060 - 财政年份:2023
- 资助金额:
$ 21.3万 - 项目类别:
Improving Outcomes in Cataract Surgery: Intraocular Lenses (IOLs) Resistant to Cell Growth
改善白内障手术的效果:抗细胞生长的人工晶状体 (IOL)
- 批准号:
10573497 - 财政年份:2023
- 资助金额:
$ 21.3万 - 项目类别:
Planning for an international symposium on patient/physician shared decision making for cataract surgery appropriateness and prioritization
规划举办关于患者/医生共同决策白内障手术适当性和优先顺序的国际研讨会
- 批准号:
461048 - 财政年份:2022
- 资助金额:
$ 21.3万 - 项目类别:
Miscellaneous Programs
Using Informatics to Evaluate and Predict Cataract Surgery Impact on Alzheimer's Disease and Related Dementias and Mild Cognitive Impairment Outcomes
利用信息学评估和预测白内障手术对阿尔茨海默病和相关痴呆症以及轻度认知障碍结果的影响
- 批准号:
10688255 - 财政年份:2022
- 资助金额:
$ 21.3万 - 项目类别:
Using Informatics to Evaluate and Predict Cataract Surgery Impact on Alzheimer's Disease and Related Dementias and Mild Cognitive Impairment Outcomes
利用信息学评估和预测白内障手术对阿尔茨海默病和相关痴呆症以及轻度认知障碍结果的影响
- 批准号:
10525214 - 财政年份:2022
- 资助金额:
$ 21.3万 - 项目类别: